Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy evaluation of a transparent barrier hydrogel for pediatric diaper dermatitis
RBR-2h6gdh7Not yet recruiting
- Sponsor
- Medcin Instituto da Pele
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of Hipoglós in diaper dermatitis (2 arms), sponsored by Medcin Instituto da Pele. Primary endpoint: Clinical efficacy of diaper rash treatment. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
Hipoglós
03
Conditions
diaper dermatitis
Beyond the preview
Go deeper on RBR-2h6gdh7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2h6gdh7.